Table 3

Patient characteristics
      Plasma cell myeloma type Disease stage Percentage of plasma cell bone marrow infiltratin Kappa/lambda ratio
IgA lambda IIIA 66.1% 0.0107
IgA lambda IIIB 28.4% 0.0514
IgA lambda IIIA 63.3% 0.1045
IgA lambda IIIA 43.5% 0.1747
IgA kappa IIA 88.2% 1.526
IgG lambda IIB 78.1% 0.00102
IgG lambda IIIB 30.3% 0.00703
IgG lambda IIIA 59.8% 0.00834
IgG lambda IIIA 20.7% 0.00127
IgG lambda IIB 66.1% 0.0161
IgG lambda IIB 59.9% 0.0115
IgG lambda IIIB 32.2% 0.0232
IgG lambda IIIA 40.1% 0.0418
IgG lambda IIIA 20.2% 0.0430
IgG lambda IIIB 20.6% 0.0509
IgG lambda IIIA 12.3% 0.0604
IgG kappa IIIA 13.4% 1.009
IgG kappa IA 37.2% 1.522
IgG kappa IA 35.0% 15.16
IgG kappa IIIb 20.4% 24.02
IgG kappa IIIA 9.8% 478.5
IgM kappa IIIA 59.5% 16.74
IgM kappa IIIA 10.5% 165.1
Bence-Jones lambda IIA 6.1% 0.0944
Bence-Jones lambda IIIA 67.0% 0.361
Bence-Jones kappa IIA 76.8% 52.66
Non-secretary lambda IIIB 41.6% 0.0672

Nakayama et al.

Nakayama et al. Diagnostic Pathology 2012 7:131   doi:10.1186/1746-1596-7-131

Open Data